J&J Rx drug sales flat, consumer and devices up
J&J flaunted the benefits of its diversified and globalized business portfolio today, reporting respectable third-quarter results despite static worldwide pharmaceutical sales of $6.1 billion.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.